Physician

Terry L Rollins, M.D.

According to 2025 Medicare claims, Terry Rollins, M.D. (NPI: 1235119116) practices dermatology in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Cape May, NJ. This provider's primary affiliated billing organization is LAWRENCE PAOLINI, DO, PC (NPI: 1962530493; TIN: 223086309) and primary practice location at 08210-2119.

Rollins' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,660 traditional Medicare patients, billed 24,932 HCPCS/CPT codes, and received $1,331,521 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 1,666 prescription claims across 641 beneficiaries totaling $1,469,910 in drug costs, led by Bimzelx Autoinjector (Bimekizumab-Bkzx). Open Payments data shows 43 records totaling $910. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $558,001 to $1,331,521. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $510,320 to $1,469,910. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$666K$1.3M2015 Medicare payment: $558,001 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $550,209 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $542,757 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $557,237 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $551,906 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $602,513 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $672,176 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $595,863 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $682,664 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,331,521 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,08912,628$558,001
20162,06913,071$550,209
20171,90612,260$542,757
20181,76221,349$557,237
20191,42916,900$551,906
20201,29917,040$602,513
20211,44218,867$672,176
20221,40818,636$595,863
20231,55020,563$682,664
20241,66024,932$1,331,521

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$735K$1.5M2015 Drug cost: $510,320 (USD; Tot_Drug_Cst)2016 Drug cost: $349,207 (USD; Tot_Drug_Cst)2017 Drug cost: $389,214 (USD; Tot_Drug_Cst)2018 Drug cost: $586,058 (USD; Tot_Drug_Cst)2019 Drug cost: $819,140 (USD; Tot_Drug_Cst)2020 Drug cost: $740,090 (USD; Tot_Drug_Cst)2021 Drug cost: $1,013,443 (USD; Tot_Drug_Cst)2022 Drug cost: $1,164,866 (USD; Tot_Drug_Cst)2023 Drug cost: $1,032,449 (USD; Tot_Drug_Cst)2024 Drug cost: $1,469,910 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154851,132$510,320
20165031,079$349,207
2017447999$389,214
20184821,074$586,058
20194401,060$819,140
20204621,144$740,090
20215931,492$1,013,443
20225651,417$1,164,866
20236891,625$1,032,449
20246411,666$1,469,910

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths328456$141
11102Biopsy of related skin growth, first growth586737$81
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,4112,578$71
17000Destruction of precancer skin growth, 1 growth1,1041,636$46
17003Destruction of precancer skin growth, 2-14 growths9457,279$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bimzelx AutoinjectorBimekizumab-Bkzx19648$273,781
Skyrizi PenRisankizumab-Rzaa131,104$268,727
OtezlaApremilast28840$134,348
Cimzia (2 Pack)Certolizumab Pegol12336$133,425
RinvoqUpadacitinib19570$120,475

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.43$910Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Terry L. Rollins, M.D.?

Tedicare shows public-source Medicare data for Terry L. Rollins, M.D. (NPI 1235119116), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Terry L. Rollins, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Terry L. Rollins, M.D.?

Terry L. Rollins, M.D. is linked to LAWRENCE PAOLINI, DO, PC (billing NPI 1962530493) in the available physician profile data.

Does Terry L. Rollins, M.D. have Open Payments data?

Terry L. Rollins, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.